Skip to main content
SpringerLink
Log in

Management of Dyspepsia in General Practice

A Critical Assessment

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

The International Gastro Primary Care Group (IGPCG) Upper Gastrointestinal Disease Management Plan is mainly characterised by the proposal that management of patients with upper gastrointestinal syndromes be based on the predominant symptom, rather than on symptom clusters. Although no study has directly tested this hypothesis in general practice, some data indirectly support the proposal. Classification based on the relevance of specific symptoms could identify distinct subgroups of patients with functional dyspepsia with at least partially different features. Data obtained from the literature are discussed and evaluated in relation to the suggested algorithm. Overall, this management plan for patients with dyspepsia seems to be both safe and effective. However, there is a need for prospective studies evaluating its actual validity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brun J, Brunton SA, Carelli F, et al. A management plan for upper gastrointestinal disease in primary care [abstract]. Gut 1996; 39 Suppl. 3: A37

    Google Scholar 

  2. Whitaker MJ, Brun J, Carelli F, et al. Controversy and consensus in the management of upper gastrointestinal disease in primary care. Int J Clin Pract 1997; 51: 1–5

    Google Scholar 

  3. Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology Int 1991; 4: 145–60

    Google Scholar 

  4. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia: report of a working party. Lancet 1988; I: 576–9

    Google Scholar 

  5. American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985; 102: 266–9

    Google Scholar 

  6. Nyrén O. Therapeutic trial in dyspepsia: its role in the primary care setting. Scand J Gastroenterol 1991; Suppl. 182: 61–9

    Google Scholar 

  7. Meineche-Schmidt V, Krag E, Christensen E. Identification of symptom clusters in 7,270 consecutive, unselected dyspepsia patients from general practice [abstract]. Gastroenterology 1996; 110: A-28

    Google Scholar 

  8. Sahagun G, Lee JG, Oehlke MA, et al. The yield of prospective endoscopic gastro-intestinal evaluation in patients with low (<50 ng/ml) ferritins [abstract]. Gastroenterology 1996; 110: A-36

    Google Scholar 

  9. Fehr HF. Risk factors, co-medication, and concomitant diseases: their influence on the outcome of therapy with cisapride. Scand J Gastroenterol 1993; 28 Suppl. 195: 40–5

    Article  Google Scholar 

  10. Talley NJ, McNeil D, Hayden A, et al. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology 1987; 92: 1060–6

    PubMed  CAS  Google Scholar 

  11. Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995; 30: 519–23

    Article  PubMed  CAS  Google Scholar 

  12. Soll AH and Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. JAMA 1996; 275: 622–9

    Article  PubMed  CAS  Google Scholar 

  13. Heatley RV, Rathbone BJ. Dyspepsia: a dilemma for doctors? Lancet 1987; II: 779–82

    Article  Google Scholar 

  14. Patel P, Khulusi S, Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315–8

    Article  PubMed  CAS  Google Scholar 

  15. Graham DY, Smit JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988; 83: 1081–5

    PubMed  CAS  Google Scholar 

  16. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: 527–32

    Article  PubMed  CAS  Google Scholar 

  17. Grant Thompson W. Non-ulcer dyspepsia. Can Med Assoc J 1984; 130: 565–9

    Google Scholar 

  18. Richter JE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 26 Suppl. 182: 11–6

    Article  Google Scholar 

  19. Johannessen T, Petersen H, Kleveland PM, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689–97

    Article  PubMed  CAS  Google Scholar 

  20. Kerrigan DD, Brown SR, Hutchinson GH. Open access gastroscopy: too much to swallow? BMJ 1990; 300: 374–6

    Article  PubMed  CAS  Google Scholar 

  21. Sobala GM, Crabtree JE, Penrith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94–6

    Article  PubMed  CAS  Google Scholar 

  22. Johnsen R, Bernersen B, Straume B, et al. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991; 302: 749–52

    Article  PubMed  CAS  Google Scholar 

  23. Halter F, Brignoli R, Omega-Project Group. Non-ulcer dyspepsia versus organic disease: evaluation of validity of discriminant symptomatology and classification in dyspepsia subtypes [abstract]. United European Gastroenterology Week 1993; Abstract book: A-4

    Google Scholar 

  24. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811–6

    Article  PubMed  CAS  Google Scholar 

  25. Hu PJ, Li YY, Zhou MH, et al. Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 1995; 36: 198–202

    Article  PubMed  CAS  Google Scholar 

  26. Bianchi Porro G, Corinaldesi R, Fiocca R, et al. Demographic and symptomatic risk indicators of organic findings at endoscopy in dyspepsia: an Italian nation-wide survey [abstract]. Gastroenterology 1996; 110: A-4

    Google Scholar 

  27. Gonvers JJ, Burnand B, Froelich F, et al. Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in a open-access endoscopy unit. Endoscopy 1996; 28: 661–6

    Article  PubMed  CAS  Google Scholar 

  28. Hallissey MT, Allum WH, Jewkes AJ, et al. Early detection of gastric cancer. BMJ 1990; 30: 513–5

    Article  Google Scholar 

  29. Williams B, Luckas M, Ellingham JHM, et al. Do young patients with dyspepsia need investigations? Lancet 1988; II: 1349–51

    Article  Google Scholar 

  30. Horrocks JC, De Dombal FT. Clinical presentation of patients with ‘dyspepsia’. Gut 1978; 19: 19–26

    Article  PubMed  CAS  Google Scholar 

  31. Morrissey JF. The diagnosis of early gastric cancer. A survey of experience in the United States. Gastrointest Endosc 1976; 23: 13–5

    Article  PubMed  CAS  Google Scholar 

  32. Olearchyk AS. Gastric carcinoma. A critical review of 243 cases. Am J Gastroenterol 1978; 70: 25–45

    PubMed  CAS  Google Scholar 

  33. MacAdam DG. A study in general practice of the symptoms and delay patterns in the diagnosis of gastrointestinal cancer. J R Coll Gen Pract 1979; 29: 723–9

    PubMed  CAS  Google Scholar 

  34. Talley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut 1987; 28: 40–6

    Article  PubMed  CAS  Google Scholar 

  35. Talley NJ, Weaver AL, Tesmer DL, et al. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378–86

    Article  PubMed  CAS  Google Scholar 

  36. Crean GP, Holden RJ, Knill-Jones RP, et al. A database on dyspepsia. Gut 1994; 35: 191–202

    Article  PubMed  CAS  Google Scholar 

  37. McColl KEL, El-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40: 302–6

    PubMed  CAS  Google Scholar 

  38. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992; 102: 1259–68

    PubMed  CAS  Google Scholar 

  39. Schlemper RJ, van der Werf SDJ, Vanderbroucke JP, et al. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol 1993; 28 Suppl. 200: 33–41

    Article  Google Scholar 

  40. Klauser AG, Voderholzer WA, Knesewitsch PA, et al. What is behind dyspepsia? Dig Dis Sci 1993; 38: 147–54

    Article  PubMed  CAS  Google Scholar 

  41. Mansi C, Savarino V, Mela GS, et al. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol 1993; 88: 1011–5

    PubMed  CAS  Google Scholar 

  42. George R, Hellier MD, Kennedy HJ, et al. Definition and subtyping of non-ulcer dyspepsia. Gastroenterology Int 1993; 6: 93–9

    Google Scholar 

  43. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia — results of a double-blind, randomised, Swiss multicentre study. Scand J Gastroenterol 1994; 29: 618–29

    Article  PubMed  CAS  Google Scholar 

  44. Trespi E, Broglia F, Villani L, et al. Distinct profiles of gastritis in dyspepsia subgroups — their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol 1994; 29: 884–8

    Article  PubMed  CAS  Google Scholar 

  45. Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671–80

    Article  PubMed  CAS  Google Scholar 

  46. Bodger K, Daly M, Heatley RV. Variations in choice of empirical therapy for dyspepsia in primary care [abstract]. Gut 1995; 37 Suppl. 2: A30

    Google Scholar 

  47. Grainger SL, Klass HJ, Rake MO, et al. Prevalence of dyspepsia: the epidemiology of overlapping symptoms. Postgrad Med J 1994; 70: 154–61

    Article  PubMed  CAS  Google Scholar 

  48. Tosetti C, Stanghellini V, Paternicò A, et al. An appropriate symptom questionnaire allows to identify separate subgroups among patients with functional dyspepsia [abstract]. Gastroenterology 1996; 110: A771

    Google Scholar 

  49. Stanghellini V, Tosetti C, Paternicò A, et al. Risk indicators of delayed gastric emptying of solids in 343 patients with functional dyspepsia. Gastroenterology 1996; 110: 1036–42

    Article  PubMed  CAS  Google Scholar 

  50. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768–74

    PubMed  CAS  Google Scholar 

  51. Klauser AG, Schindlebeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205–8

    Article  PubMed  CAS  Google Scholar 

  52. Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983; 78: 257–60

    PubMed  CAS  Google Scholar 

  53. Warndorff DK, Knottnerus JA, Huijnen LGL, et al. How well do general practitioners manage dyspepsia? J R Coll Gen Pract 1989; 39: 499–502

    PubMed  CAS  Google Scholar 

  54. Loof L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993; 28: 113–8

    Article  PubMed  CAS  Google Scholar 

  55. Verhaeghe J, Jacques N, Rombouts J, et al. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices. Scand J Gastroenterol 1993; 28 Suppl. 195: 25–35

    Article  Google Scholar 

  56. Heading RC, Dyspepsia Study Steering Committee. Multicentre UK dyspepsia study [abstract]. Gastroenterology 1993; 104 Suppl.: A11

    Google Scholar 

  57. Heyse PM, Rambaldo R, Hazelhoff B. Factors affecting short and long term outcome of a short therapeutic trial with cisapride in dyspeptic patients. Scand J Gastroenterol 1993; 28 Suppl. 195: 15–24

    Article  Google Scholar 

  58. Bernstern B, Johnsen R, Straume B, et al. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996; 38: 822–5

    Article  Google Scholar 

  59. Carlsson R, Dent J, Glise H, et al. Evaluation of a questionnaire for the diagnosis of symptomatic gastroesophageal reflux disease [abstract]. Gastroenterology 1996; 110: A-76

    Google Scholar 

  60. Holtmann G, Neufang-Hober J, Talley NJ, et al. Pattern of symptoms in functional dyspepsia: predictors of a response to treatment? [abstract]. Gastroenterology 1996; 110: A-680

    Google Scholar 

  61. Dent J, Watts R, Riley S, et al. Gastroesophageal reflux disease in primary care — an international placebo controlled study of different treatment strategies with omeprazole [abstract]. Gastroenterology 1996; 110: A-93

    Google Scholar 

  62. Kellow JE, Cowan H, Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 153–60

    Article  PubMed  CAS  Google Scholar 

  63. Tytgat G, Janssens J, Reynolds C, et al. Update on the pathophysiology and management of gastro-oesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol 1996; 8: 603–11

    Article  PubMed  CAS  Google Scholar 

  64. Newton M, Bryan R, Burnham WR, et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barretts oesophagus. Gut 1997; 40: 9–13

    PubMed  CAS  Google Scholar 

  65. Labenz J, Tillenberg B, Peitz U, et al. Incidence of reflux esophagitis after cure of Helicobacter pylori infection in duodenal ulcer patients [abstract]. Gastroenterology 1995; 108: A140

    Google Scholar 

  66. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long term safety. Am J Gastroenterol 1995; 90: 1401–6

    PubMed  CAS  Google Scholar 

  67. Malagelada JR. Gastrointestinal motor disturbances in functional dyspepsia. Scand J Gastroenterol 1991; 26 Suppl. 182: 29–32

    Article  Google Scholar 

  68. Dobrilla G, Comberlato M, Steele A, et al. Drug treatment of functional dyspepsia — a meta-analysis of randomised controlled trials. J Clin Gastroenterol 1989; 11: 169–77

    Article  PubMed  CAS  Google Scholar 

  69. Archimandritis A, Tzivras M, Emmanuel A, et al. Cisapride, metoclopramide and ranitidine in the treatment of severe nonulcer dyspepsia. Clin Ther 1992; 14: 553–61

    PubMed  CAS  Google Scholar 

  70. Jian R, Ducrot F, Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 657–64

    Article  PubMed  CAS  Google Scholar 

  71. Corinaldesi R, Stanghellini V, Raiti C, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987; 28: 300–5

    Article  PubMed  CAS  Google Scholar 

  72. Hovelius B, Andersson SI, Hagander B, et al. Dyspepsia in general practice and symptoms in relation to Helicobacter pylori serum antibodies. Scand J Gastroenterol 1994; 29: 506–10

    Article  PubMed  CAS  Google Scholar 

  73. Kemmer TP, Dominguez-Munoz JE, Klingel H, et al. The association between non-ulcer dyspepsia and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 571–7

    Article  Google Scholar 

  74. Deltenre M, Nyst JF, Jonas C, et al. Données cliniques, endoscopiques et histologiques chez 1100 patients dont 574 colonises par Campylobacter pylori. Gastroenterol Clin Biol 1989; 13: 89B–95B

    PubMed  CAS  Google Scholar 

  75. Buda A, Bortolon M, Saladin S, et al. Usefulness of symptomatological pattern in predicting the outcome of dyspeptic patients after Hp eradication: a prospective six months study [abstract]. Gut 1996; 39 Suppl. 3: A147

    Google Scholar 

  76. Graham DY, Malaty HM, Evans Jr DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495–501

    PubMed  CAS  Google Scholar 

  77. Bernstern B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276–9

    Article  Google Scholar 

  78. Talley NJ. The role of Helicobacter pylori in nonulcer dyspepsia — A debate — Against. Gastroenterol Clin N Am 1993; 22: 153–67

    CAS  Google Scholar 

  79. Czinn SJ, Bertram TA, Murray PD, et al. Relationship between gastric inflammation response and symptoms in patients infected with Helicobacter pylori. Scand J Gastroenterol 1991; 26 Suppl. 181: 33–7

    Article  Google Scholar 

  80. Braden B, Caspary WF, Lembcke B. The density of gastric Helicobacter pylori colonisation is not associated with the severity of symptoms in functional dyspepsia [abstract]. Gastroenterology 1996; 110: A-63

    Google Scholar 

  81. Veldhuyzen van Zanten SJ, Malatjalian D, Tanton R, et al. The effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia: a randomised double-blind placebo controlled trial [abstract]. Gut 1995; 37 Suppl. 3: A56

    Google Scholar 

  82. McCarthy C, Patchett S, Collins RM, et al. Long term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114–9

    Article  PubMed  CAS  Google Scholar 

  83. Elta GH, Scheiman JM, Barnett JL, et al. Long-term follow up of Helicobacter pylori treatment in non ulcer dyspepsia patients. Am J Gastroenterol 1995; 90: 1089–93

    PubMed  CAS  Google Scholar 

  84. Sheu B, Lin C, Lin X, et al. Long-term outcome of triple therapy in Helicobacter pylori related non-ulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol 1996; 91: 441–7

    PubMed  CAS  Google Scholar 

  85. Greenberg PD, Cello JP. Prospective, double-blind treatment of Helicobacter pylori in patients with non-ulcer dyspepsia [abstract]. Gastroenterology 1996; 110: A-123

    Article  Google Scholar 

  86. Talley NJ. A critique of therapeutic trials in Helicobacter pyloripositive functional dyspepsia. Gastroenterology 1994; 106: 1174–83

    PubMed  CAS  Google Scholar 

  87. Lasser AT, Bytzer P, Schaffalitzky de Muckadell OB. H. pylori testing or prompt endoscopy for dyspeptic patients in primary care. A randomised controlled trial of two management strategies. Gastroenterology 1997; 112 (4): A24

    Google Scholar 

  88. Kahn KL, Greenfield S. The efficacy of endoscopy in the evaluation of dyspepsia: a review of the literature and development of a sound strategy. J Clin Gastroenterol 1986; 8: 346–58

    Article  PubMed  CAS  Google Scholar 

  89. Goodson JD, Lehmann JW, Richter JM, et al. Is upper gastrointestinal radiography necessary in the initial management of uncomplicated dyspepsia? J Gen Inter Med 1989; 4: 367–74

    Article  CAS  Google Scholar 

  90. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988; 232: 75–8

    PubMed  CAS  Google Scholar 

  91. Gotthard R, Bodemar G, Brodin U, et al. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18

    Article  PubMed  CAS  Google Scholar 

  92. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26 Suppl. 182: 47–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Practice, National Health System, Porretta Terme, via Rosselli 21, I-40046, Bologna, Italy

    Cesare Tosetti

  2. Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy

    Vincenzo Stanghellini

Authors
  1. Cesare Tosetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincenzo Stanghellini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tosetti, C., Stanghellini, V. Management of Dyspepsia in General Practice. Pharmacoeconomics 14 (Suppl 2), 57–66 (1998). https://doi.org/10.2165/00019053-199814002-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199814002-00006

Keywords

Search

Navigation